Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients.
Stephen Tsang, MD, PhD
Advertisement
Articles by Stephen Tsang, MD, PhD
Advertisement
Latest Updated Articles
Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trialsPublished: November 13th 2025 | Updated:
Advertisement
Advertisement